| Daniel P. O’Day | Chairman and Chief Executive Officer | FY2025 | |
| Dietmar Berger | M.D., Ph.D. Chief Medical Officer | FY2025 | |
| Johanna Mercier | Chief Commercial and Corporate Affairs Officer | FY2025 | |
| Andrew D. Dickinson | Chief Financial Officer | FY2025 | |
| Deborah H. Telman | Former Executive Vice President, Corporate Affairs and General Counsel | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.